Skip to main content

Intraindividual sleep variations; Phisical activity, diet, CVD and Cancer; Early Microbiome and siblings





How much sleeps vary from night-to-night? 

Age, gender, and racial/ethnic identity all significantly influence how much and how effectively we typically sleep. 

There is an increase in studying the significance of intraindividual variability (IIV) in sleep from night to night. A recent study compared racial/ethnic, age and gender groups.  

Younger adults had more diary and actigraphy sleep duration variability.  

Gender differences were inconsistent.

White and non-Hispanic/Latin adults had lower IIV scores for sleep efficiency and duration. The quality of sleep varies greatly from night to night, even among healthy sleepers. 

Similar to mean sleep, intraindividual variability in sleep may vary depending on demographic factors. Results from this study is hoped to define the normative levels of sleep IIV in healthy sleepers.

Physical activity, diet quality and all-cause cardiovascular disease and cancer mortality

Independent and interactive associations of physical activity and diet with all-cause, cardiovascular disease (CVD) and physical activity, diet and adiposity-related (PDAR) cancer mortality were examined.

A study involving 346 627 individuals is based on the UK Biobank data with linkage to the National Health Service death records to 30 April 2020. 

The associations between exposures (self-reported total moderate-to-vigorous intensity physical activity (MVPA), vigorous-intensity physical activity (VPA) and a diet quality index (score ranged 0-3)) and outcomes (all-cause, CVD and PDAR cancer mortality) were measured.

Although not reaching statistical significance, being in the best dietary category (diet quality index=2-3) was associated with a reduction in PDAR cancer mortality. 

No additive or multiplicative interactions between physical activity categories and dietary quality was found. 

The lowest risk combinations consistently included the higher levels of physical activity and the highest diet quality score.


Growing up with siblings has been linked to numerous health outcomes and is also an important determinant for the developing microbiota. Nonetheless, research into the role of having siblings on the developing microbiota has mainly been incidental. 

The effects of having siblings on airway and gut microbiota were measured using 4497 hypopharyngeal and fecal samples taken from 686 children in the COPSAC2010 cohort (Danish mother-child population based longitudinal clinical), starting at 1 week of age and continuing until 6 years of age. 

Having siblings is one of the most important factors influencing a child's developing microbiota, and the specific effects may explain previously established associations between siblings and asthma and infectious diseases. 

As such, siblings should be considered in all studies involving the developing microbiota, with emphasis on the age gap to the closest older sibling rather than the number of siblings. 


Sixty OCD outpatients were assessed for their beliefs in and experiences of free will at baseline and after one year of treatment.
OCD sufferers frequently feel forced to engage in (compulsive) actions, which calls into question their beliefs and experiences about free choice. 

Older individuals or those with a greater severity of symptoms seem to have a perception of decreased free will. 

In addition, patients with a longer duration of illness tend to have a lower strength of belief in determinism. 

Finally, the experience of being the owner of the compulsions, along with the baseline severity of symptoms, can be a predictor of a worse outcome in the OCD sample.


Comments

Popular posts from this blog

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable

The safety of aspartame is under review by WHO after conflicting findings.

Aspartame, a sweetener with health effects Since 1981, the WHO expert committee on additives has confirmed the safety of aspartame consumption within acceptable daily limits. The international organization has established that the acceptable daily intake (ADI) of aspartame is 40 milligrams per kilogram of body weight. This means that a person can consume up to 40 mg of aspartame per kilogram of their body weight per day without risking their health. For example, if someone weighs 60 kilos, the allowable amount of aspartame would be 2,400 milligrams (40 mg/kg x 60 kg). In recent years, several studies have been carried out on the effects of aspartame on health. The Food and Drug Administration (FDA) has reviewed the scientific evidence related to the safety of this sweetener five times since its approval in 1981, and has concluded that it remains safe for use. However, it is being studied again. It has an especially important use in low-calorie beverages consumed by children and pregnan

Light Therapy holds promise as a treatment for Alzheimer's Disease

A new article, conducted by Lili Zang and colleagues from Weifang Medical University School of Nursing in Shandong Province, China, discusses a meta-analysis of 15 high-quality trials that investigated the impact of light therapy on individuals with Alzheimer’s disease (AD). The meta-analysis included 598 patients with mild to moderate Alzheimer’s disease, and it covered 15 randomized controlled trials conducted in seven different countries. Those trials were published between 2005 and 2022. Sleep Improvement Light therapy led to significant improvements in several sleep measures. It notably enhanced sleep efficiency, increased interdaily stability, and reduced intradaily variability, all of which are indicators of better sleep quality. Light therapy was associated with a reduction in agitation, depression, and caregiver burden among individuals with Alzheimer’s disease. A significant advantage over usual care was shown in reducing the severity of psychobehavioral symptoms, as assessed